<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Akme Fintrade (India) Ltd. (AFIL) — Tipsheet</title>
    <link>https://tipsheet.markets/company/afil/</link>
    <atom:link href="https://tipsheet.markets/company/afil/feed.xml" rel="self" type="application/rss+xml" />
    <description>Every Tipsheet Editorial note covering Akme Fintrade (India) Ltd. (AFIL), newest first. Grounded in BSE/NSE primary-source filings.</description>
    <language>en-in</language>
    <lastBuildDate>Mon, 06 Jul 2026 10:22:46 GMT</lastBuildDate>
    <item>
      <title>Akme Fintrade raises ₹25 cr via NCDs, a small but steady debt raise</title>
      <link>https://tipsheet.markets/afil-akme-fintrade-raises-25-cr-via-ncds-a-small-but-steady-debt-raise-118753/</link>
      <guid isPermaLink="true">https://tipsheet.markets/afil-akme-fintrade-raises-25-cr-via-ncds-a-small-but-steady-debt-raise-118753/</guid>
      <pubDate>Fri, 03 Jul 2026 13:11:33 GMT</pubDate>
      <description>The NBFC&#39;s loan committee approved listed, secured NCDs on a private placement basis. At 5.5% of market cap, the raise is modest and within the ₹1,200 cr borrowing limit already disclosed.</description>
      <content:encoded><![CDATA[<p><em>The NBFC's loan committee approved listed, secured NCDs on a private placement basis. At 5.5% of market cap, the raise is modest and within the ₹1,200 cr borrowing limit already disclosed.</em></p>
<h3>What’s new</h3><ul><li>Akme Fintrade’s committee approved NCD issuance up to ₹25 cr.</li><li>NCDs will be listed on NSE with security cover of 1.1x over loan receivables.</li><li>The debt is part of the company's ₹1,200 cr borrowing limit.</li></ul>
<h3>Why it matters</h3><p>The NCD raise is incremental, just 5.5% of market cap, and does not signal a strategic shift. It shows steady execution of the funding plan without straining the balance sheet, given a debt/equity of 0.74.</p>
<h3>What we’re watching</h3><ul><li>Coupon and tenure details in the KID for each series.</li><li>Whether Akme Fintrade accelerates debt issuance in coming quarters.</li><li>Impact on debt/equity ratio after the full NCD allocation.</li></ul>
<h3>The full read</h3><p>Akme Fintrade is raising <strong>₹25 cr</strong> through listed NCDs, a small fraction of its <strong>₹442 cr</strong> market cap and part of the <strong>₹1,200 cr</strong> borrowing limit already on the books. The deal is modest: at <strong>5.5%</strong> of market cap, it barely nudges the debt/equity ratio of <strong>0.74</strong>. The company's latest quarter showed <strong>₹43 cr</strong> sales and <strong>₹12 cr</strong> net profit, with trailing revenue growth of <strong>45.5%</strong> and PAT growth of <strong>62.6%</strong>. The NCD terms include security cover of at least <strong>1.1x</strong> over eligible loan receivables, a conservative structure. This is incremental funding, not a strategic pivot. The open question is the coupon, but for now, the raise is routine.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=544200&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=AFIL">NSE</a></p>]]></content:encoded>
      <category>Other</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Akme Fintrade seeks ₹1,200 cr borrowing limit, dwarfing its ₹442 cr market cap</title>
      <link>https://tipsheet.markets/afil-akme-fintrade-seeks-1-200-cr-borrowing-limit-dwarfing-its-442-cr-market-cap-116309/</link>
      <guid isPermaLink="true">https://tipsheet.markets/afil-akme-fintrade-seeks-1-200-cr-borrowing-limit-dwarfing-its-442-cr-market-cap-116309/</guid>
      <pubDate>Mon, 29 Jun 2026 17:38:52 GMT</pubDate>
      <description>The nano-cap NBFC&#39;s board approved a massive increase in borrowing capacity, subject to shareholder approval. The authorization would allow the lender to scale its loan book far beyond its current size.</description>
      <content:encoded><![CDATA[<p><em>The nano-cap NBFC's board approved a massive increase in borrowing capacity, subject to shareholder approval. The authorization would allow the lender to scale its loan book far beyond its current size.</em></p>
<h3>What’s new</h3><ul><li>Board approved raising borrowing limits to ₹1,200 crore, from an undisclosed prior level.</li><li>Warrant conversions will bring in ₹5.25 crore; authorised capital upped to ₹60 crore.</li><li>New statutory auditor recommended; shareholder vote needed for all proposals.</li></ul>
<h3>Why it matters</h3><p>For a nano-cap NBFC with ₹43 crore quarterly sales and a 0.74x debt/equity ratio, a ₹1,200 crore borrowing limit is a bet-the-farm growth ambition. If shareholders approve, the company's risk profile shifts dramatically — it can now borrow nearly three times its entire market cap.</p>
<h3>What we’re watching</h3><ul><li>Shareholder vote at the upcoming annual meeting.</li><li>Management's planned deployment of that debt capacity.</li><li>Any credit rating review or regulatory scrutiny given the size.</li></ul>
<h3>The full read</h3><p>Akme Fintrade's board is asking shareholders to hand it a loaded gun. The proposed borrowing limit of <strong>₹1,200 crore</strong> is nearly three times its entire <strong>₹442 crore</strong> market cap, for a nano-cap NBFC that did <strong>₹43 crore</strong> in quarterly sales and carries just <strong>0.74x</strong> debt-to-equity today. The warrant conversions that accompanied this news raise only <strong>₹5.25 crore</strong>, a rounding error compared to the firepower the company now seeks. The analyst rationale calls the move 'genuinely new'. What it really is: a leveraged bet on growth that would, if approved, change everything about Akme Fintrade's risk profile. Shareholders vote next. They'll decide whether <strong>₹1,200 crore</strong> is ambition or overreach.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=544200&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=AFIL">NSE</a></p>]]></content:encoded>
      <category>Other</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Akme Fintrade cuts its warrant raise by 39% despite having approval for more.</title>
      <link>https://tipsheet.markets/afil-akme-fintrade-cuts-its-warrant-raise-by-39-despite-having-approval-for-more-94640/</link>
      <guid isPermaLink="true">https://tipsheet.markets/afil-akme-fintrade-cuts-its-warrant-raise-by-39-despite-having-approval-for-more-94640/</guid>
      <pubDate>Thu, 21 May 2026 18:54:21 GMT</pubDate>
      <description>The NBFC allotted 7.5 crore convertible warrants, well short of the 12.25 crore it had green light. Non-promoters took two-thirds.</description>
      <content:encoded><![CDATA[<p><em>The NBFC allotted 7.5 crore convertible warrants, well short of the 12.25 crore it had green light. Non-promoters took two-thirds.</em></p>
<h3>What’s new</h3><ul><li>Akme Fintrade allotted 7.5 crore convertible warrants at ₹7 each, raising ₹13.1 crore upfront.</li><li>Promoters took 2.5 crore warrants; non-promoters took 5 crore, bringing in external investors.</li><li>The final allotment is 39% smaller than the 12.25 crore warrants for which in-principle approval was received.</li></ul>
<h3>Why it matters</h3><p>The raise is materially smaller than what was sanctioned. For an NBFC, the potential ₹52.5 crore equity infusion would be 13.2% of its ₹399 crore market cap. The mix of promoter and non-promoter participation is a positive signal. The cut in quantum, however, demands an explanation that the filing does not provide.</p>
<h3>What we’re watching</h3><ul><li>Whether Akme seeks approval for the unused warrants from the original plan.</li><li>How the ₹13.1 crore upfront cash is deployed into the lending book.</li><li>The stock's ability to stay above the ₹7 strike price for conversion within 18 months.</li></ul>
<h3>The full read</h3><p>Akme Fintrade raised <strong>₹13.1 crore</strong> in cash by issuing <strong>7.5 crore</strong> convertible warrants at <strong>₹7</strong> each. Promoters subscribed to <strong>2.5 crore</strong> of them. Non-promoter investors took <strong>5 crore</strong>, bringing in external capital. The bigger story is the shortfall. The company had approval for <strong>12.25 crore</strong> warrants but allotted <strong>39% less</strong>. If every warrant converts, Akme will pull in a total of <strong>₹52.5 crore</strong>, or <strong>13.2%</strong> of its <strong>₹399 crore</strong> market cap. That is a material boost for a small NBFC's equity base. The cut is sharp. No reason was given. The open question is whether the unused portion of the original approval still sits on the table.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=544200&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=AFIL">NSE</a></p>]]></content:encoded>
      <category>Credit</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
  </channel>
</rss>